Information Provided By: 
Fly News Breaks for January 8, 2018
PODD
Jan 8, 2018 | 08:01 EDT
As previously reported, Raymond James upgraded Insulet (PODD) to Outperform from Market Perform and established an $80 price target. Analyst Jayson Bedford has increased confidence in estimates from several tailwinds that include a share gain opportunity in US insulin pumps following Johnson & Johnson's (JNJ) exit from the market in September, incremental Medicare reimbursement for OmniPod, potential growth as it enters new countries, and the expected launch of its new Bluetooth-enabled OmniPod and PDM, its first new product in five years.
News For PODD From the Last 2 Days
There are no results for your query PODD
